Approximately 40,000 babies are born each year with congenital heart defects — the most common type of major birth defect in the U.S. But, a new valve being used at the University of Michigan’s C.S. Mott Children’s Hospital Congenital Heart Center is helping patients delay or avoid multiple open-heart surgeries.
The new Melody™ Transcatheter Pulmonary Valve is inserted through a catheter into a vein in the patient’s leg during a heart catheterization, rather than an open-heart procedure. On Sunday, U-M’s Dr. Aimee Armstrong presented data to the American College of Cardiology that reaffirmed the safety and efficacy of the valve, which has been FDA approved for Humanitarian Use Device designation since Jan. 2010. Read here for more details on that presentation. C.S. Mott Children’s Hospital’s Congenital Heart Center was the first hospital in the state, and one of the first in the country, approved to use the valve in patients.
25-year-old Patrick Nolan is one of those patients. Under the care of Dr. Armstrong, Patrick was able to get the heart valve he needed in 2011 without having to undergo yet another open-heart procedure. Today, he is a hard-working med student hoping to become a pediatric cardiologist, in part due to his experience as a cardiac patient and the dedicated doctors he’s met along the way.
Patrick shares his inspiring story…